BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 29309563)

  • 1. Neoadjuvant chemoradiation radiation dose levels for surgically resectable esophageal cancer: predictors of use and outcomes.
    Buckstein M; Rhome R; Ru M; Moshier E
    Dis Esophagus; 2018 May; 31(5):. PubMed ID: 29309563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low- vs. High-Dose Neoadjuvant Radiation in Trimodality Treatment of Locally Advanced Esophageal Cancer.
    Ji KSY; Thomas SM; Roman SA; Czito B; Anderson KL; Frakes J; Adam MA; Sosa JA; Robinson TJ
    J Gastrointest Surg; 2019 May; 23(5):885-894. PubMed ID: 30374818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment utilization and outcomes in elderly patients with locally advanced esophageal carcinoma: a review of the National Cancer Database.
    Vlacich G; Samson PP; Perkins SM; Roach MC; Parikh PJ; Bradley JD; Lockhart AC; Puri V; Meyers BF; Kozower B; Robinson CG
    Cancer Med; 2017 Dec; 6(12):2886-2896. PubMed ID: 29139215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Neoadjuvant Radiation Dose on Patients Undergoing Esophagectomy and Survival in Locally Advanced Esophageal Cancer.
    Ising MS; Marino K; Trivedi JR; Rojan AA; Dunlap NE; van Berkel V; Fox MP
    J Gastrointest Surg; 2019 Apr; 23(4):670-678. PubMed ID: 30788714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients.
    Fujiwara Y; Yoshikawa R; Kamikonya N; Nakayama T; Kitani K; Tsujie M; Yukawa M; Inoue M; Yamamura T
    Oncol Rep; 2012 Aug; 28(2):446-52. PubMed ID: 22664791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of survival among neoadjuvant chemoradiation responders, non-responders and patients receiving primary resection for locally advanced oesophageal squamous cell carcinoma: does neoadjuvant chemoradiation benefit all?
    Hsu PK; Chien LI; Huang CS; Hsieh CC; Wu YC; Hsu WH; Chou TY
    Interact Cardiovasc Thorac Surg; 2013 Sep; 17(3):460-6. PubMed ID: 23728085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing failure patterns of radical intent radiation strategies in patients with locally advanced carcinoma of the esophagus.
    Mishra S; Ahmad F; Singh S; Singh RK; Das KJM; Kumar S
    Cancer Rep (Hoboken); 2021 Jun; 4(3):e1332. PubMed ID: 33369258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of standardized clinical pathways: refining multidisciplinary care and process to improve outcomes of the surgical treatment of esophageal cancer.
    Markar SR; Schmidt H; Kunz S; Bodnar A; Hubka M; Low DE
    J Gastrointest Surg; 2014 Jul; 18(7):1238-46. PubMed ID: 24777435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locally advanced esophageal carcinoma: is there still a role of surgery alone without neoadjuvant treatment?
    Reeh M; Nentwich MF; Asani S; Uzunoglu FG; Bockhorn M; Sauter G; Rösch T; Izbicki JR; Bogoevski D
    J Gastrointest Surg; 2015 Apr; 19(4):587-93. PubMed ID: 25652343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes following neoadjuvant chemoradiotherapy for esophageal cancer.
    Reynolds JV; Muldoon C; Hollywood D; Ravi N; Rowley S; O'Byrne K; Kennedy J; Murphy TJ
    Ann Surg; 2007 May; 245(5):707-16. PubMed ID: 17457163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with Non-response to Neoadjuvant Chemoradiation for Esophageal Cancer Have No Survival Advantage over Patients Undergoing Primary Esophagectomy.
    Chevrollier GS; Giugliano DN; Palazzo F; Keith SW; Rosato EL; Evans Iii NR; Berger AC
    J Gastrointest Surg; 2020 Feb; 24(2):288-298. PubMed ID: 30809782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERCC1 RNA expression in peripheral blood predicts minor histopathological response to neoadjuvant radio-chemotherapy in patients with locally advanced cancer of the esophagus.
    Brabender J; Vallböhmer D; Grimminger P; Hoffmann AC; Ling F; Lurje G; Bollschweiler E; Schneider PM; Hölscher AH; Metzger R
    J Gastrointest Surg; 2008 Nov; 12(11):1815-21. PubMed ID: 18769985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-Dose Radiation Yields Lower Rates of Pathologic Response in Esophageal Cancer Patients.
    Mantziari S; Farinha HT; Messier M; Winiker M; Allemann P; Ozsahin EM; Demartines N; Piessen G; Schäfer M
    Ann Surg Oncol; 2024 Apr; 31(4):2499-2508. PubMed ID: 38198002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting outcomes in esophageal adenocarcinoma following neoadjuvant chemoradiation: Interactions between tumor response and survival.
    Solomon D; Deeb AL; Tarabine K; Xie Y; Mazzola E; Zhao L; Hammer MM; Jaklitsch MT; Swanson SJ; Bueno R; Wee JO
    J Thorac Cardiovasc Surg; 2024 Jul; 168(1):278-289.e4. PubMed ID: 37967764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation dose in neoadjuvant chemoradiation therapy for esophageal cancer: patterns of care and outcomes from the National Cancer Data Base.
    Haque W; Verma V; Butler EB; Teh BS
    J Gastrointest Oncol; 2018 Feb; 9(1):80-89. PubMed ID: 29564174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locally Advanced Adenocarcinoma of the Esophagus: Is Esophagectomy Associated with Improved Overall Survival?
    Kramer SP; Swanson J; Fernando M; Park S; Verm R; Abdelsattar Z; Cohn T; Luchette FA; Baker MS
    J Am Coll Surg; 2024 Jul; 239(1):68-75. PubMed ID: 38483131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress in multidisciplinary treatment for patients with esophageal cancer.
    Watanabe M; Otake R; Kozuki R; Toihata T; Takahashi K; Okamura A; Imamura Y
    Surg Today; 2020 Jan; 50(1):12-20. PubMed ID: 31535225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esophagogastric Cancer: The Current Role of Radiation Therapy.
    Tchelebi LT; Goodman KA
    Hematol Oncol Clin North Am; 2024 Jun; 38(3):569-583. PubMed ID: 38485552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Use of Trimodality Treatment in Patients With Locally Advanced Oesophageal Squamous Cell Carcinoma: An Experience From a Large Cancer Centre in Pakistan.
    Qamar MFU; Hanif H; Haider I; Khaleeq N; Misbah D; Inam Y; Anjum M
    Cureus; 2023 Oct; 15(10):e47835. PubMed ID: 38021746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive registry of esophageal cancer in Japan, 2012.
    Tachimori Y; Ozawa S; Numasaki H; Ishihara R; Matsubara H; Muro K; Oyama T; Toh Y; Udagawa H; Uno T;
    Esophagus; 2019 Jul; 16(3):221-245. PubMed ID: 31098822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.